Form 8-K - Current report:
SEC Accession No. 0001206774-22-000656
Filing Date
2022-03-10
Accepted
2022-03-10 16:21:03
Documents
14
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gern4032181-8k.htm   iXBRL 8-K 24647
2 PRESS RELEASE DATED MARCH 10, 2022 gern403218ex991.htm EX-99.1 64262
3 GRAPHIC gern403218ex991x1x1.jpg GRAPHIC 8302
  Complete submission text file 0001206774-22-000656.txt   285732

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gern-20220310.xsd EX-101.SCH 3016
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220310_pre.xml EX-101.PRE 22353
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220310_lab.xml EX-101.LAB 34240
8 EXTRACTED XBRL INSTANCE DOCUMENT gern4032181-8k_htm.xml XML 3594
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 22729320
SIC: 2834 Pharmaceutical Preparations